CompuGroup Medical SE & Co. KGaA (ETR:COP – Get Rating) received a €65.00 ($67.01) price target from investment analysts at Jefferies Financial Group in a research report issued on Thursday, Borsen Zeitung reports. Jefferies Financial Group’s target price points to a potential upside of 55.95% from the stock’s previous close.
Other research analysts also recently issued research reports about the stock. Warburg Research set a €67.50 ($69.59) price objective on shares of CompuGroup Medical SE & Co. KGaA in a report on Monday, August 1st. Baader Bank set a €81.00 ($83.51) target price on shares of CompuGroup Medical SE & Co. KGaA in a research report on Tuesday, July 26th. Kepler Capital Markets set a €53.00 ($54.64) target price on shares of CompuGroup Medical SE & Co. KGaA in a research report on Monday, June 20th. Deutsche Bank Aktiengesellschaft set a €68.00 ($70.10) price objective on shares of CompuGroup Medical SE & Co. KGaA in a report on Tuesday, July 5th. Finally, Berenberg Bank set a €76.00 ($78.35) price objective on shares of CompuGroup Medical SE & Co. KGaA in a research note on Friday, May 6th.
CompuGroup Medical SE & Co. KGaA Price Performance
Shares of COP opened at €41.68 ($42.97) on Thursday. The company has a current ratio of 0.85, a quick ratio of 0.74 and a debt-to-equity ratio of 112.51. The firm has a market cap of $2.18 billion and a PE ratio of 31.28. CompuGroup Medical SE & Co. KGaA has a 1-year low of €36.30 ($37.42) and a 1-year high of €82.80 ($85.36). The firm has a fifty day simple moving average of €42.79 and a two-hundred day simple moving average of €49.40.
CompuGroup Medical SE & Co. KGaA Company Profile
CompuGroup Medical SE & Co KGaA develops and sells software and information technology solutions for the healthcare sector worldwide. It operates in four segments: Ambulatory Information Systems (AIS), Pharmacy Information Systems (PCS), Hospital Information Systems (HIS), and Consumer & Health Management Information Systems (CHS).
- MarketBeat: Week in Review 8/1 – 8/5
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Cronos Group Inc’s Revenues Are Up, Is It Time to Buy?
- Beyond Meat Is Not Beyond Hope, And It’s Cheap
- Why Apple Could Be At All-Time Highs By Year End
Receive News & Ratings for CompuGroup Medical SE & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CompuGroup Medical SE & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.